(GLSI) – Corporate News
-
Greenwich LifeSciences (GLSI) Extends Lock-up of Directors and Officers to June 30, 2025
-
Greenwich LifeSciences (GLSI) Announces Flamingo-01 Phase III Clinical Trial Approved to Expand into Five EU Countries
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GLSI Stock Lookup